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PCoronary Artery Disease
he Number of Endothelial Progenitor Cell
olonies in the Blood Is Increased in Patients
ith Angiographically Significant Coronary Artery Disease
asan Güven, MD,* Rebecca M. Shepherd, MD,† Richard G. Bach, MD, FACC,*
enjamin J. Capoccia, BS,‡ Daniel C. Link, MD‡
t. Louis, Missouri
OBJECTIVES The objective of this study was to determine whether the number of endothelial progenitor
cells (EPCs) and circulating angiogenic cells (CACs) in peripheral blood was associated with
the presence and severity of coronary artery disease (CAD) in patients undergoing coronary
angiography.
BACKGROUND Previous studies have suggested an inverse relationship between levels of circulating
EPCs/CACs and the presence of CAD or cardiovascular risk factors, whereas other studies
have observed increased numbers of EPCs in the setting of acute ischemia. However, the
criteria used to identify specific angiogenic cell subpopulations and methods of evaluating
CAD varied in these studies. In the present study, we used rigorous criteria to identify EPCs
and CACs in the blood of patients undergoing coronary angiography.
METHODS The number of EPCs and CACs were measured in the blood of 48 patients undergoing
coronary angiography. Patients with acute coronary syndromes were excluded.
RESULTS Compared with patients without angiographically significant CAD, the number of EPCs was
increased (1.11  2.50 vs. 4.01  3.70 colonies/well, p  0.004) and the number of CACs
trended higher (175  137 vs. 250  160 cells per mm2, p  0.09) among patients with
significant CAD. The highest levels of EPCs were isolated from patients subsequently
selected for revascularization (5.03  4.10 colonies/well).
CONCLUSIONS In patients referred for coronary angiography, higher numbers of EPCs, and a trend toward
higher numbers of CACs, were associated with the presence of significant CAD, and EPC
number correlated with maximum angiographic stenosis severity. Endothelial progenitor cell
levels were highest in patients with CAD selected for revascularization. (J Am Coll Cardiol
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.04.1012006;48:1579–87) © 2006 by the American College of Cardiology Foundation
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iost-natal neovascularization, or neoangiogenesis, was orig-
nally thought to result exclusively from the proliferation
nd migration of mature endothelial cells from pre-existing
lood vessels, until the recent demonstration that a popu-
ation of leukocytes in the blood could differentiate into
ndothelial cells in vitro and contribute to neoangiogenesis
n vivo (1). Evidence has now accumulated that bone-
arrow–derived cells with angiogenic capability, loosely
See page 1588
ermed endothelial progenitor cells (EPCs), circulate in the
lood of adults (2,3). Endothelial progenitor cells possess
he ability to home to sites of vascular injury and contribute
o neoangiogenesis (4). As a consequence, there has been
onsiderable interest in the therapeutic use of EPCs to
timulate angiogenesis after vascular injury. Early clinical
rials suggest that local infusion of cell populations contain-
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rants from the National Institutes of Health (R01 HL073762 to Dr. Link and T32
L 07088-23 to Dr. Shepherd).T
Manuscript received December 5, 2005; revised manuscript received March 29,
006, accepted April 4, 2006.ng EPCs may improve revascularization after myocardial
nfarction or other vascular syndromes (5–8).
The capacity of circulating EPCs to repair vascular
amage suggests that they may play a key role in maintain-
ng homeostasis of the endothelium. It follows that the
umber of circulating EPCs may reflect the “vascular
ealth” of an individual. Nevertheless, the relationship
etween circulating EPCs and vascular diseases, particularly
therosclerosis, remains controversial and incompletely un-
erstood. A limited number of studies have examined the
ssociation between the circulating EPC and coronary
rtery disease (CAD). Both an inverse correlation between
he level of circulating EPC and the presence of risk factors
or CAD (9,10), and a reduced number of circulating EPCs
efined as CD34 or CD34KDR cells, in patients with
ngiographically documented CAD compared with healthy
ontrols have been reported (11,12). Others have observed
hat the number of circulating EPCs is increased in patients
ith acute myocardial infarction (AMI) and unstable isch-
mic syndromes (13,14), positively correlates with collateral
oronary blood flow in patients with CAD (15), and may
ncrease in response to exercise-induced ischemia (16,17).
hus, the relationship between the level of circulating EPCs
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CACs and EPCs in Patients Undergoing Catheterization October 17, 2006:1579–87nd the development of, presence of, and severity of CAD
emain unclear.
Previous studies of EPC biology may have been ham-
ered by the lack of uniform criteria to precisely identify
PCs. Classically, EPCs have been recognized based on
heir growth under culture conditions designed to stimulate
ndothelial cell growth. However, there is now growing
vidence that among circulating cells with angiogenic ca-
acity there are subpopulations with distinct marker phe-
otypes and potentially distinct roles. Previous studies
uggest that at least 2 cell populations capable of mediating
ngiogenesis can be identified in cultures of blood mono-
uclear cells (18,19). True EPCs (also termed late out-
rowth endothelial progenitors, henceforth termed EPCs)
re cells with endothelial progenitor capacity (20). Though
xpression of CD34, CD133, and KDR defines a cell
opulation enriched for EPCs, they are most reliably
easured by their ability to produce large colonies of mature
ndothelial cells in vitro (21). Several studies have described
second angiogenic cell population in these cultures
18,19). These cells, termed circulating angiogenic cells
CACs) or early EPCs (henceforth termed CACs), are
dherent and express certain markers associated with mature
onocytes/macrophages but do not express CD34 or
D133. Circulating angiogenic cells secrete large amounts
f angiogenic growth factors, including vascular endothelial
Table 1. Baseline Characteristics
No Significant CAD
Age (yrs) 59 (38–85
Male gender (%) 48
Diabetes (%) 39
Smoking history (%) 70
Hypertension (%) 52
Hypercholesterolemia (%) 52
Family history of CAD (%) 30
ACE-I use (%) 61
Statin use (%) 52
WBC (cells/l) 7,935
Lymphocytes (cells/l) 2,055
Monocytes (cells/l) 590
Max coronary stenosis (%) 19.2  24
Revascularization† (%) 0
*Significant CAD was defined as 1 or more coronary artery oc
Abbreviations and Acronyms
AMI  acute myocardial infarction
CABG  coronary artery bypass grafting
CAC  circulating angiogenic cell
CAD  coronary artery disease
EPC  endothelial progenitor cell
FITC  fluorescein isothiocynate
hs-CRP  high-sensitivity C-reactive protein
LDL  low-density lipoprotein
PBS  phosphate buffered saline
VEGF  vascular endothelial growth factorpercutaneous coronary intervention or coronary artery bypass graft
ACE-I  angiotensin-converting enzyme inhibitor; CAD  crowth factor (VEGF). Importantly, both EPCs and CACs
re able to stimulate neoangiogenesis in animal models of
ascular injury (18).
In the present study, we use rigorous criteria to measure
PCs and CACs in the blood of patients referred for
ardiac catheterization in whom the presence and severity of
AD was assessed by coronary angiography. Our results
how that the number of EPCs and CACs isolated from the
lood is increased in patients with angiographically signif-
cant CAD.
ETHODS
tudy protocol. The protocol was approved by the Insti-
utional Review Board at Washington University School of
edicine. Forty-eight patients undergoing cardiac cathe-
erization were enrolled in the study. Inclusion criteria
ncluded the ability to give informed consent and referral for
oronary angiography for the evaluation of CAD. Exclusion
riteria included the presence of an AMI, unstable coronary
yndrome, unstable angina, prior coronary artery bypass
urgery (CABG), prior coronary angioplasty or stenting,
re-menopausal state or pregnancy, presence of diabetic
etinopathy, the presence of symptomatic peripheral vascu-
ar disease, underlying infection, cancer, immune suppres-
ion, end-stage renal or liver disease, or being initiated on a
tatin within the past 3 months. In 5 patients, technical
roblems precluded EPC enumeration. The clinical profile
f the patients is shown in Table 1.
ngiogenic cell culture. After placement of an arterial
heath, 3 to 5 ml of blood was wasted and then 30 ml of
hole blood obtained for cell culture. The heparinized
pecimen was diluted with phosphate buffered saline (PBS),
nd the specimen was centrifuged across a 1.077 density
radient (Histopaque, Sigma-Aldrich, St. Louis, Missouri)
t 1,700  g for 30 min. The isolated mononuclear cells
ere suspended in EGM-2 medium (Cambrex Bio Science,
alkersville, Maryland) supplemented with 20% fetal calf
erum and plated onto a 6-well cell culture plate coated with
 24) Significant CAD* (n  24) p Value
66 (46–79) 0.69
65 0.27
25 0.33
70 0.97
85 0.03
85 0.03
30 0.97
30 0.95
75 0.12
7,385 0.46
1,725 0.14
540 0.38
88.7  11 0.0001
65 0.0001
ns 70%; †subsequent revascularization procedures included* (n
)
clusio
ing.
oronary artery disease; WBC  white blood cell.
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October 17, 2006:1579–87 CACs and EPCs in Patients Undergoing Catheterization.2% gelatin (Corning Life Sciences, Acton, Massachusetts)
t a concentration of 5 million cells/well. The cell media was
eplenished every 4 days after a gentle washing with
hosphate-buffered saline to remove non-adherent cells.
he number of CACs was assessed on days 7 to 12 on
ulture. Twenty fields of view were assessed by random field
maging at 200 magnification with a Nikon inverted
icroscope with a grid lens by an observer who was blinded
o the clinical profile of the patients. Endothelial progenitor
ells were assessed on days 12 to 28 of culture by scanning
ulture plates for discrete colonies. Because a similar amount
f blood was analyzed for each sample, the data are reported
s the number of CACs per mm2 or EPCs per well. A
imilar reporting system has been used in previously pub-
ished reports (10,13,22,23). Complete EPC and CAC
ulture data were available for 43 and 48 patients,
espectively.
mmunofluorescence. Cells were incubated in 1,1=
ioctadecyl-3,3,3=,3=-tetramethyindocarbocyanide-labeled
cetylated low-density lipoprotein (Dil-Ac-LDL) at 10
g/ml in EGM2 media at 37°C for 4 h (Biomedical
echnologies, Staughton, Massachusetts). Cells were then
ashed in PBS and fixed in 3% formaldehyde/PBS for 20
in at room temperature. Ulex-lectin staining was per-
ormed by incubating cells with fluorescein isothiocynate
FITC)-conjugated Ulex europeaus agglutinin I (ulex-lectin,
igma, St. Louis, Missouri) for 1 h at 4°C. Cells were
ashed with PBS before visualization using a Nikon
icrophot-SA fluorescent microscope.
low cytometry. Adherent cells were washed twice with
BS and detached with Cell Dissociation Buffer (Invitrogen
orporation, Carlsbad, California) for 20 min at 37°C. The
ells were then resuspended in fluorescence activated cell
orting buffer (0.1% sodium azide, 0.2% bovine serum
lbumin, 1 mM ethylenediaminetetraacetic acid in PBS)
nd incubated with Fc block (Miltenyi Biotec, Auburn,
alifornia) for 10 min at 4°C followed by incubation with 1
f the following antibodies: phycoerythrin-conjugated
D14, CD45, CD34; FITC-conjugated CD31 (all from
D Biosciences, San Diego, California); CD105 (BD
iosciences) conjugated to Alexa Fluor 488 using monoclo-
al antibody labeling kit (Molecular Probes, Eugene, Ore-
on); FITC-conjugated CD-144 (VE-cadherin) (Novus
iologicals, Littleton, Colorado). Fluorescent isotype-
atched antibodies were used as negative controls. The cells
ere analyzed on a FACScan flow cytometer using Cell
uest analysis software (Becton-Dickinson, Franklin
akes, New Jersey) (24).
ssessment of CAD severity. Coronary angiography was
erformed using 4-F or 6-F catheters at a standard 30
rames/s and stored on digital media. Angiograms were
ndependently reviewed by 2 cardiologists who were blinded
o the results of EPC and CAC cultures and to the clinical
istory and outcomes. To underscore clinical relevance, and
iven the limitations of quantitative coronary angiography
or assessing the entire coronary tree (24), stenosis severity was assessed by visual estimation. In accordance with lesion
everity previously correlated with reduced coronary flow
eserve (25) and with clinical standards recognized in the
merican College of Cardiology/American Heart Associa-
ion guidelines for coronary angiography (26), patients with
evere disease had at least 1 coronary stenosis of 70%.
oronary arteries were considered normal when angiograms
howed smooth lumens with no stenoses 30%. Moderate
isease was considered present when angiograms showed
tenosis of 30% to 70%. Patients were selected for
evascularization by percutaneous coronary intervention or
ABG at the discretion of the referring cardiologist.
igh-sensitivity C-reactive protein (hs-CRP). Serum
s-CRP was measured on blood samples collected at the
ime of coronary angiography using an immunonephelo-
etric assay on a BN II analyzer (Dade Behring, Deerfield,
llinois).
tatistical analysis. Data are expressed as mean values 
EM unless otherwise indicated. Statistical significance was
ssessed using chi-square analysis or logistic regression. For
omparisons of data with more than 2 categorical groups,
he Fisher exact test was applied. The correlation between
aximal coronary artery stenosis and EPC or CAC number
as assessed using the Spearman rank test. A p value of
0.05 was considered statistically significant.
ESULTS
easurement of EPCs and CACs. We first established
riteria to rigorously identify EPCs and CACs. Standard
ethods were used to culture freshly isolated blood mono-
uclear cells under conditions that favor endothelial cell
rowth (19). Endothelial progenitor cells were identified by
he formation of discrete colonies of endothelial cells on
ays 14 to 28 of culture. Cells in these colonies stained with
lex-lectin and took up acetylated LDL (Fig. 1). These cells
xpressed high levels of the endothelial antigens CD34,
D31, CD105, and CD144 but were largely negative for
he leukocyte antigens CD45 and CD14 (Fig. 2). Circulat-
ng angiogenic cells were identified as adherent spindle-
haped cells that stained for ulex-lectin and took up acety-
ated LDL (Fig. 1). Consistent with previous reports
18,19), these cells expressed the leukocyte antigens CD45
nd CD14 but were generally negative for the endothelial
ntigens CD34, CD105 (endoglin), and CD144 (VE cad-
erin) (Fig. 2). CD31 (platelet/endothelial cell adhesion
olecule-1), which is normally expressed at high levels on
ndothelial cells and weakly on leukocytes, was expressed at
low level on CACs. Herein, we report the number of
irculating EPCs and CACs based on the culture-based
ssays described above. However, it should be noted that
ulture-based assays, by their nature, provide an indirect
easure of the number of circulating EPCs and CACs. In
he population studied, the level of EPCs and CACs did not
ary significantly according to age, systolic blood pressure,
hite blood cell count, serum glucose, serum creatinine, the
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CACs and EPCs in Patients Undergoing Catheterization October 17, 2006:1579–87resence of hypertension, diabetes mellitus, or cigarette
moking (all p  NS, data not shown).
atient characteristics. Patients were divided into groups
y the presence or absence of significant (70% diameter
tenosis) CAD by angiography. Baseline characteristics of
he 2 groups are shown in Table 1. The average maximum
tenosis in the patients without and with significant CAD
as 19.2%  24% and 87.0%  16%, respectively (p 
.0001). Hypertension and hypercholesterolemia were more
requent among patients with significant CAD. The total
hite blood cell, neutrophil, lymphocyte, and monocyte
ounts were similar between the 2 groups (all p  0.10).
The number of EPCs is increased in patients with
ngiographically significant CAD. When compared with
atients with no significant CAD, peripheral blood ob-
ained from the patients with angiographically significant
AD yielded a greater number of circulating EPCs (1.11
.5 vs. 4.01 3.70 EPC colonies per well, respectively, p
.004; Fig. 3A). Logistic regression showed that the odds of
aving angiographically significant CAD increased by 38%
or each unit increase in EPCs (odds ratio 1.38, 95%
onfidence interval 1.07 to 1.77; p  0.01). For those
atients with greater than 4 EPCs per well (n  12), the
igure 1. Phenotype of circulating angiogenic cells (CAC) and endotheli
CAC) or day 21 (EPC) of culture are shown in the left and right panel
emonstrates staining for Ulex-lectin; and the lower panel shows DiI-labe
100.dds ratio increased to 6.43 with a 95% confidence interval pf 1.32 to 31.3 (p  0.02). A significant association of EPC
umber and angiographically significant CAD was still
bserved after adjusting for age, gender, cardiac risk factors,
eft ventricular ejection fraction, angiotensin-converting en-
yme inhibitor or statin use.
Levels of EPCs were then stratified by dividing patients
nto groups according to the maximum angiographic steno-
is severity: 30%, n  13; 30% to  70%, n  10; and
70%, n 20 (Fig. 3C). The number of EPCs was highest
mong the patients with angiographically severe disease
4.01  3.70 colonies per well), lower among patients with
ntermediate severity CAD (1.78  3.1 colonies per well),
nd significantly lower among patients with normal coro-
ary arteries (0.59  1.8 colonies per well, p  0.0006 vs.
evere CAD). A significant correlation was observed be-
ween the maximum stenosis severity and the number of
PCs (r  0.57, p  0.00005) (Fig. 4A). When patients
ere divided according to number of vessels with significant
tenosis, there was no significant difference in the number of
PCs isolated between patients with 1-, 2-, or 3-vessel
AD (Fig. 5A). After angiographic assessment, 13 of 43
tudy patients were selected by their clinician, independent
f this study, for a revascularization procedure. These
genitor cells (EPC). Representative photomicrographs of cells on day 7
pectively. The top panel shows phase contrast images; the middle panel
etylated-low density lipoprotein uptake (LDL-U). Original magnificational pro
s, resatients had a significantly higher number of EPCs com-
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October 17, 2006:1579–87 CACs and EPCs in Patients Undergoing Catheterizationared with patients who did not have revascularization
5.03  4.10 vs. 1.34 2.34 colonies/well, respectively, p
.0006) (Fig. 5C).
The number of CACs is elevated in patients with
ngiographically significant CAD. Peripheral blood ob-
ained from the patients without and with significant CAD
ielded an average of 175 137 CACs per mm2 and 250 
60 CACs per mm2, respectively (p  0.09) (Fig. 3B).
hen divided according to degree of CAD (Fig. 3D), the
ighest number of CACs was observed in the peripheral
lood of the 24 patients with at least 1 stenosis 70%
250  160 per mm2), a lower level among the 10 patients
ith moderate severity disease (190  122 per mm2), and
he lowest level among the 14 patients with no stenosis
30% (165 150 per mm2), although these differences did
ot reach statistical significance. A significant correlation
as observed between the maximum stenosis severity and
he level of CAC (r 0.36, p 0.01) (Fig. 4B), whereas no
ignificant correlation was observed between coronary ste-
osis severity and the white blood cell, lymphocyte, or
onocyte count assessed in the same peripheral blood (data
ot shown). When patients were divided according to
umber of diseased vessels, the greatest number of CACs
ere isolated from the blood of patients with severe 3-vessel
AD (349  182 per mm2, p  0.08 vs. patients with no
tenosis 30%) (Fig. 5B). Patients who were subsequently
igure 2. Cell surface phenotype of circulating angiogenic cells and endo
catter (SSC-H) histograms of cultures on day 7 and 21 of culture. The gate
n day 7 (upper panel) and day 21 (lower panel). Isotype controls are shelected independently to undergo revascularization (n  c6) had a significantly higher number of CACs compared
ith patients who did not have revascularization (287 182
s. 175  121 per mm2, respectively, p  0.01) (Fig. 5D).
The number of EPCs or CACs does not correlate with
erum hs-CRP. In blood collected from the 48 study
atients simultaneously with the samples used to determine
PC or CAC number, the levels of hs-CRP were measured.
y linear regression, there was no correlation observed
etween the serum level of hs-CRP and either EPCs or
ACs (Figs. 6A and 6B); the results were similar when the
nalysis was repeated and patients with significant CAD
ere excluded (data not shown).
ISCUSSION
n this study, we examined the hypothesis that the level of
irculating EPCs and CACs was associated with the pres-
nce and/or severity of CAD. Because uniform criteria to
dentify these cells were lacking, an emphasis was placed in
his study on distinguishing CACs from EPCs. As shown
reviously, we demonstrate that CACs are CD45 leuko-
ytes that express the monocytic marker CD14 (18,19).
onsistent with previous reports (18,19), these cells secrete
EGF and are able to stimulate angiogenesis in a murine
odel of hindlimb ischemia (20). In contrast, EPCs are true
rogenitor cells that form discrete colonies in a culture
l progenitor cells. (A) Representative forward scatter (FSC-H) and side
to analyze cells are shown. (B) Representative histograms of cells analyzed
s green lines.theliaomprised mainly of mature endothelial cells. In fact,
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CACs and EPCs in Patients Undergoing Catheterization October 17, 2006:1579–87ngram et al. (20) have shown that EPCs are capable of
xponential growth in vitro, achieving at least 100 cell
oublings. True EPCs are exceedingly rare in peripheral
lood with an estimated frequency in healthy volunteers of
EPC per 20 ml of blood (21). This translates to a
requency of approximately 1 EPC per 100 million leuko-
ytes, making EPCs difficult to reliably quantify by flow
ytometry without prior sample purification.
Previous studies have examined the relationship between
irculating EPCs and CAD or risk factors predisposing to
AD. Hill et al. (9) reported that the number of circulating
igure 3. Number of endothelial progenitor cells (EPC) (A and C) and ci
ith significant coronary artery disease (stenosis 70% vs. 70%; A and B
0%, and 70% (C and D), as assessed by coronary angiography.
igure 4. Correlation of endothelial progenitor cell (EPC) (A) and circul
iameter coronary stenosis. Spearman rank correlation was used to assess statistPCs, identified as cell colonies on day 9 of culture that
tained with VEGFR2, CD31, and BS1-lectin and took up
cetylated LDL, correlated inversely with cardiac risk fac-
ors. In that study, CAD was not directly assessed. Vasa
t al. (10) observed an inverse correlation between the
umber of circulating EPCs and both cardiac risk factors
nd angiographically documented CAD. In their analysis,
PC were identified as cells present on day 4 of culture that
tained with ulex-lectin and took up acetylated LDL or by
ow cytometry to detect CD34VEGFR2 cells in the
lood. Eizawa et al. (11) reported that the number of
ing angiogenic cells (CAC) (B and D) isolated from patients without and
d among patients stratified by maximum coronary stenosis 30%, 30% to
angiogenic cell (CAC) (B) number with maximum angiographic percentrculatical significance.
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October 17, 2006:1579–87 CACs and EPCs in Patients Undergoing Catheterizationirculating CD34 cells in the blood inversely correlated
ith the presence of angiographically documented CAD
11). However, the control group with “no CAD” in that
tudy did not undergo coronary angiography. In the largest
tudy to date, Werner et al. (12) observed an inverse
ssociation between the level of circulating EPCs and the
isk of cardiovascular events among patients with angio-
raphically documented CAD. Endothelial progenitor cells
ere measured by flow cytometry as CD34KDR cells
nd, in a subset of patients, using a culture-based method.
owever, colonies were only scored on day 7 of culture,
hereas, as shown by Ingram et al. (21), many endothelial
olonies only appear after 10 to 14 days. With respect to the
orrelations between EPCs and angiographic or clinical end
igure 5. Number of endothelial progenitor cells (EPC) (A and C) and c
umber of vessels with stenosis 70% (A and B), and by subsequent clini
umber of vessels with stenosis 70%.igure 6. Correlation of endothelial progenitor cell (EPC) (A) and circulating a
hsCRP).oints, all comparisons in this study were performed with
D34KDR cells quantified by flow cytometry. It should
lso be noted that patients in whom no CAD was detected
y angiography were excluded from the study population,
nd the relationship between EPC number and the severity
f angiographic CAD was not specified in this report.
In the present study, we observed that the number of
PCs positively correlates with the presence and severity of
AD, with the highest number of EPCs detected in
atients with angiographically significant CAD selected for
revascularization procedure. Likewise, a trend towards
igher CAC number and severity of CAD was observed.
hough the results of our study may superficially appear to
e at odds with the above studies, there are fundamental
ting angiogenic cells (CAC) (B and D) observed in patients stratified by
cision for revascularization (C and D). Revasc  revascularization; W irculangiogenic cell (CAC) (B) number with high-sensitivity C-reactive protein
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CACs and EPCs in Patients Undergoing Catheterization October 17, 2006:1579–87ifferences in the methodologies that likely account for the
ifferent results. Importantly, the types of EPCs measured
n these studies may well be distinct. For example, in the
tudy by Werner et al. (12), EPCs were primarily measured
y flow cytometry as CD34KDR cells. In contrast, we
pplied the rigorous criteria outlined by Ingram et al. (21) to
dentify EPCs as cells that formed colonies of mature
ndothelial cells after 7 to 21 days in culture with angiogenic
rowth factors. That these 2 methodologies measure dis-
inct cell types is best illustrated by their frequency in the
lood. Whereas the frequency of CD34KDR cells in the
lood, as reported by Werner et al. (12), was 12 to 1,039
ells/ml, the frequency of true EPCs in our study was 0.05
o 1 per ml of blood. Collectively, these data are consistent
ith the emerging concept that several blood cell popula-
ions with angiogenic activity exist (e.g., true EPC and
D34KDR cells) that have distinct biological properties
nd are regulated by distinct mechanisms.
There is previous evidence suggesting that coronary
schemia may be associated with an increase in the level of
irculating EPCs. Massa et al. (14) showed that the number
f CD34CD133VEGR2 cells in the blood was in-
reased in patients with AMI compared with healthy
ontrols or patients with stable CAD. In addition, using a
ulture-based system to identify EPCs, George et al. (13)
eported that circulating EPC number was increased in
atients with unstable angina compared with patients with
table angina. Interestingly, clinical stabilization of angina
n patients with unstable angina in that cohort resulted in a
-fold decrease in circulating EPC number. Finally, more
ecent studies have directly observed that exercise-induced
schemia is associated with an increase in numbers of
irculating EPC (16,17). In the present study, we show that
PC number was significantly elevated in patients with at
east 1 angiographic stenosis of 70%. Although the
lassification of significant CAD based on this criteria is
omewhat arbitrary, it has been previously correlated with
educed coronary flow reserve and is a widely accepted
hreshold with clinical relevance as a surrogate for hemody-
amic significance (26–28). In our series of generally
ymptomatic patients, the majority classified with signifi-
ant CAD by study criteria underwent surgical or percuta-
eous revascularization, whereas all of the patients indepen-
ently classified without significant CAD were managed
onservatively. It is notable, therefore, that in our study, the
ighest number of EPCs was observed in patients who
nderwent a revascularization procedure. Collectively, these
ata suggest that coronary ischemia may be a proximal
eterminant of EPC number in the blood.
Although currently speculative, there are several mecha-
istic possibilities that might account for the increase in
PCs in patients with coronary ischemia. First, it has been
stablished that EPCs can be mobilized from the bone
arrow to blood in response to a variety of inflammatory
ytokines, including granulocyte colony-stimulating factor
nd granulocyte-macrophage colony-stimulating factor s29–31), and coronary ischemia has been associated with
ystemic inflammation (32,33). Thus, the increased level of
PCs in patients with coronary ischemia might reflect EPC
obilization from the bone marrow in response to inflam-
atory cytokine signals. Indeed, previous studies have
uggested that the serum level of CRP, a marker of systemic
nflammation that has been correlated with mortality from
AD (32,33), may positively correlate with the number of
irculating EPCs (13,34). However, in the present study, no
ignificant correlation between EPC number in the blood
nd serum CRP was observed. A second possibility is
uggested by the recent report that EPCs reside within the
ascular endothelium (35). It is possible that ischemic
amage to the endothelium may result in the release of
PCs into the blood, and this release of EPCs from the
asculature may be sufficient to significantly elevate circu-
ating EPC number. Consistent with this hypothesis, Lee
t al. (36) reported that mature endothelial cells were
ncreased in the circulation in patients with acute coronary
yndromes.
tudy limitations. As previously described, recent evidence
uggests the presence of at least 2 populations of angiogenic
ells in the circulation, EPCs and CACs. However, it is
ossible that other angiogenic cell populations may exist
hat might alter the interpretation of these data. Moreover,
here is suggestive evidence that EPCs as measured in this
tudy represent a heterogenous population of endothelial
rogenitors with differing proliferative capacity (21). It is
ossible that stratifying EPCs based on their proliferative
tatus may provide additional insights. In addition, the
umber of subjects in our study was relatively small, and
ome group comparisons may have lacked power to detect
ignificant differences for select variables. The classification
f significant CAD based on visual estimation of the
ngiographic percent stenosis of coronary artery lesions at
70% is admittedly arbitrary. However, within the range of
ngiographically significant CAD including lesions of
70%, this criteria of stenosis severity has been correlated
ith physiologic significance and has relevance to com-
only applied angiographic standards and is widely ac-
epted clinical practice (26–28).
onclusions. The results of the current study demonstrate
hat among patients referred for coronary angiography, the
umber of EPCs in the blood is increased in association
ith angiographically significant CAD, with a trend toward
igher CACs. Given these observed associations, the signals
timulating angiogenic cell proliferation or release, the role
f these cells in the progression or stabilization of vascular
isease, and their impact on clinical outcome remain im-
ortant topics for further study.
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